Literature DB >> 25787028

[Differential diagnosis of oral mucosal erosions and ulcers in children].

S Benoit1, H Hamm.   

Abstract

BACKGROUND: Oral ulcers and erosions are of great clinical importance because they are common in childhood and adolescence and generally painful. They can be related to harmless conditions, such as recurrent aphthous stomatitis. On the other hand, they can be associated with severe systemic diseases making an early diagnosis and initiation of treatment necessary.
OBJECTIVES: We herein focus on the systematic presentation of differential diagnoses of oral ulcers and erosions in pediatric patients and present clues in the history and clinical features that are helpful to establish the diagnosis.
CONCLUSIONS: Patient's age at the beginning of the symptoms, differentiation between acute and chronic course, distribution of mucosal lesions, additional involvement of the skin, extracutaneous symptoms, general condition of the patient, comorbidities and medication may be determining factors of the correct diagnosis. In children and adolescents aphthous stomatitis, infections and trauma are the most frequent causes of oral ulcerations or erosions of the mucous membranes.

Entities:  

Mesh:

Year:  2015        PMID: 25787028     DOI: 10.1007/s00105-015-3601-5

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  33 in total

Review 1.  Autoimmune bullous skin diseases. Part 1: Clinical manifestations.

Authors:  Andrea Kneisel; Michael Hertl
Journal:  J Dtsch Dermatol Ges       Date:  2011-10       Impact factor: 5.584

Review 2.  Urban legends: recurrent aphthous stomatitis.

Authors:  L Baccaglini; R V Lalla; A J Bruce; J C Sartori-Valinotti; M C Latortue; M Carrozzo; R S Rogers
Journal:  Oral Dis       Date:  2011-08-04       Impact factor: 3.511

Review 3.  Behçet's disease: an algorithmic approach to its treatment.

Authors:  Erkan Alpsoy; Ayse Akman
Journal:  Arch Dermatol Res       Date:  2009-08-21       Impact factor: 3.017

Review 4.  Cutaneous manifestations of gastrointestinal disease: part II.

Authors:  Breck Thrash; Mahir Patel; Kejal R Shah; C Richard Boland; Alan Menter
Journal:  J Am Acad Dermatol       Date:  2013-02       Impact factor: 11.527

Review 5.  Fifteen-minute consultation: a structured approach to the management of recurrent oral ulceration in a child.

Authors:  Kirsty Le Doare; Esther Hullah; Stephen Challacombe; Esse Menson
Journal:  Arch Dis Child Educ Pract Ed       Date:  2013-09-19       Impact factor: 1.309

6.  Co-circulation of coxsackieviruses A6 and A10 in hand, foot and mouth disease outbreak in Finland.

Authors:  Soile Blomqvist; Päivi Klemola; Svetlana Kaijalainen; Anja Paananen; Marja-Leena Simonen; Tytti Vuorinen; Merja Roivainen
Journal:  J Clin Virol       Date:  2010-02-26       Impact factor: 3.168

Review 7.  Clinical features, diagnosis, and treatment of erythema multiforme: a review for the practicing dermatologist.

Authors:  Olayemi Sokumbi; David A Wetter
Journal:  Int J Dermatol       Date:  2012-08       Impact factor: 2.736

8.  Dermatological spectrum of hand, foot and mouth disease from classical to generalized exanthema.

Authors:  Thomas Hubiche; Isabelle Schuffenecker; Franck Boralevi; Christine Léauté-Labrèze; Laure Bornebusch; Christine Chiaverini; Alice Phan; Annabel Maruani; Juliette Miquel; Marie-Edith Lafon; Bruno Lina; Pascal Del Giudice
Journal:  Pediatr Infect Dis J       Date:  2014-04       Impact factor: 2.129

9.  [Blistering autoimmune diseases of childhood].

Authors:  M Goebeler; D Zillikens
Journal:  Hautarzt       Date:  2002-12-20       Impact factor: 0.751

10.  Epidermolysis Bullosa Oropharyngeal Severity (EBOS) score: a multicenter development and reliability assessment.

Authors:  Giulio Fortuna; Nita Chainani-Wu; Francina Lozada-Nur; Massimo Aria; Rodrigo Cepeda-Valdes; Annamaria Pollio; M Peter Marinkovich; Adriana E Martinez-Salazar; Michele D Mignogna; Anna L Bruckner; Julio Cesar Salas-Alanís
Journal:  J Am Acad Dermatol       Date:  2012-05-08       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.